Literature DB >> 9848294

Ovarian stimulation and borderline ovarian tumors: a case-control study.

B J Mosgaard1, O Lidegaard, S K Kjaer, G Schou, A N Andersen.   

Abstract

OBJECTIVE: To assess the risk of borderline ovarian cancer among infertile women treated with fertility drugs.
DESIGN: Case-control study.
SETTING: Nationwide data obtained from public registers and postal questionnaires. PATIENT(S): All Danish women <60 years old with borderline ovarian cancer during the period 1989-1994 and randomly selected population controls. The analysis included 231 cases and 1,721 controls. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Influence of parity, infertility, and fertility drugs on the risk of borderline ovarian cancer after multivariate confounder control. RESULT(S): The odds ratio (OR) for borderline ovarian cancer among infertile untreated nulliparous women compared with fertile nulliparous women was 1.9. The OR for borderline ovarian cancer among treated nulliparous women compared with untreated infertile nulliparous women was 1.5, and the OR among treated parous women compared with untreated infertile parous women was 1.5. CONCLUSION(S): Among fertile women, the difference in the risk of borderline ovarian cancer between nulliparous women and parous women was not statistically significant. Nulliparous women who were infertile and who did not receive medical treatment had a twofold higher risk of borderline ovarian cancer than fertile nulliparous women. There was no statistically significant increase in the risk of borderline ovarian cancer among nulliparous women who were treated with fertility drugs compared with nulliparous untreated infertile women or among parous women who were treated with fertility drugs compared with parous untreated infertile women.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9848294     DOI: 10.1016/s0015-0282(98)00337-9

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  13 in total

1.  Long term health consequences of polycystic ovarian syndrome: a review analysis.

Authors:  A Daniilidis; K Dinas
Journal:  Hippokratia       Date:  2009-04       Impact factor: 0.471

Review 2.  Use of fertility drugs and risk of ovarian cancer.

Authors:  Brenda Diergaarde; Michelle L Kurta
Journal:  Curr Opin Obstet Gynecol       Date:  2014-06       Impact factor: 1.927

3.  Ovulation-inducing drugs and ovarian cancer risk: results from an extended follow-up of a large United States infertility cohort.

Authors:  Britton Trabert; Emmet J Lamb; Bert Scoccia; Kamran S Moghissi; Carolyn L Westhoff; Shelley Niwa; Louise A Brinton
Journal:  Fertil Steril       Date:  2013-09-05       Impact factor: 7.329

4.  Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility.

Authors:  Ivana Rizzuto; Renee F Behrens; Lesley A Smith
Journal:  Cochrane Database Syst Rev       Date:  2019-06-18

Review 5.  Use of fertility medications and cancer risk: a review and update.

Authors:  Lindsay Kroener; Daniel Dumesic; Zain Al-Safi
Journal:  Curr Opin Obstet Gynecol       Date:  2017-08       Impact factor: 1.927

6.  Use of fertility drugs and risk of ovarian cancer: results from a U.S.-based case-control study.

Authors:  Michelle L Kurta; Kirsten B Moysich; Joel L Weissfeld; Ada O Youk; Clareann H Bunker; Robert P Edwards; Francesmary Modugno; Roberta B Ness; Brenda Diergaarde
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-06-15       Impact factor: 4.254

7.  Cancer Risk in Women Treated with Fertility Drugs According to Parity Status-A Registry-based Cohort Study.

Authors:  Marte Myhre Reigstad; Ritsa Storeng; Tor Åge Myklebust; Nan Birgitte Oldereid; Anne Katerine Omland; Trude Eid Robsahm; Louise Annette Brinton; Siri Vangen; Kari Furu; Inger Kristin Larsen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-01-20       Impact factor: 4.254

Review 8.  A Potential Pathogenic Link Between Cancer of Female Reproductive System and Infertile Women Treated With Assisted Reproduction Techniques.

Authors:  Michail Diakosavvas; Zacharias Fasoulakis; Thomas Ntounis; Antonios Koutras; Kyveli Angelou; Georgios Tsatsaris; Athanasios Syllaios; Nikolaos Garmpis; Emmanuel N Kontomanolis
Journal:  In Vivo       Date:  2021-04-28       Impact factor: 2.155

9.  Fertility preservation for cancer patients: a review.

Authors:  Tosin Ajala; Junaid Rafi; Peter Larsen-Disney; Richard Howell
Journal:  Obstet Gynecol Int       Date:  2010-03-31

10.  Fertility drug use and the risk of ovarian tumors in infertile women: a case-control study.

Authors:  Albert Asante; Phoebe H Leonard; Amy L Weaver; Ellen L Goode; Jani R Jensen; Elizabeth A Stewart; Charles C Coddington
Journal:  Fertil Steril       Date:  2013-04-01       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.